祖拉诺:第一次获得批准
1Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. dru@adis.com.
祖拉诺是一种新型神经活性类固醇,已被批准用于治疗产后抑郁症. 这标志着通过向GABA-A受体来开发情绪障碍的新疗法的一个重要里程碑.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 产后抑郁症 (PPD) 是一种影响分娩后妇女的严重情绪障碍.
- 现有的PPD治疗方法存在局限性,需要新的治疗方法.
- 调节胺酸A (GABAA) 受体的神经活性类固醇在情绪障碍方面表现有前途.
研究的目的:
- 总结一下祖拉诺的关键发展里程碑.
- 为了突出监管途径导致首次批准苏拉诺.
- 为了提供苏拉诺作为产后抑郁症治疗的概述.
主要方法:
- 对祖拉诺的临床前和临床开发数据的审查.
- 对监管机构提交和批准的分析.
- 苏拉诺作为GABAA受体的阳性全调节剂的药理学表征.
主要成果:
- 苏拉诺是一种口服的神经活性类固醇,在产后抑郁症的临床试验中显示出有效性.
- 圣疗法和Biogen通过开发来推进祖兰.
- 在2023年8月,祖拉诺获得了美国首次批准,用于患有PPD的成年人.
结论:
- 祖拉诺代表了一种新的口服治疗情绪障碍的新类药物,特别是产后抑郁症.
- 批准意味着基于神经类固醇的疗法取得了突破.
- 进一步的步骤包括美国毒品执法局 (DEA) 的调度.
更多相关视频
06:20Contrast-Enhanced Subharmonic Aided Pressure Estimation SHAPE Using Ultrasound Imaging with a Focus on Identifying Portal Hypertension
Published on: December 5, 2020
08:40Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs
Published on: April 19, 2024
相关概念视频
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
